1955: Quanterix (NASDAQ: QTRX) Biomarker Detection Technology

Kevin Hrusovsky, CEO of Quanterix and the Powering Precision Health Summit founder, joins me on the Tech Talks Daily Podcast. Kevin has more than 25 years of experience leading life sciences and biotechnology companies and believes that accelerating precision medicine is the key to changing our current healthcare system and improving the population's longevity. Two years ago, he founded the Powering Precision Health Summit as a way to bring all key stakeholders – including doctors, scientists, patients, patient advocates, investors, innovators, etc., together to discuss how we can accelerate research and turn today's sickcare into tomorrow's healthcare. He sees collaboration as the key for advancing our healthcare system and currently sits on the board of several life science companies, to ensure that all medical milestones are capitalized on. Finally, Kevin believes the ability to track the environment's impact on our health is key for helping move the needle forward. He grew up in a coal mining town and from an early age became fascinated with how environmental factors dictate our health. He has found that protein biomarkers can track a person's health as it changes over time, which can enable doctors to spot diseases before they occur, and is working to advance digital technologies that can measure these biomarkers in real time.

We discuss how biomarker technology is enabling researchers to see and monitor health conditions that were previously impossible to study in blood, including COVID-19, TBIs, Alzheimer's, MS, cancer and more. I learn how this tech is making a tremendous impact by identifying diseases much earlier in the disease progression opens the floodgates to new and better treatment outcomes.